The Medical News

from News-Medical.Net - Latest Medical News and Research from Around the World


Researchers discover cardioprotective genetic variant in isolated Greek population

Fri, 26 May 2017 07:38:17 -0400

A genetic variant that protects the heart against cardiovascular disease has been discovered by researchers at the Wellcome Trust Sanger Institute and their collaborators.

Preventing newborn baby deaths in ambulances with new stretcher

Fri, 26 May 2017 06:14:32 -0400

Academics and industry partners in Birmingham are developing a new device that will ensure newborn babies could survive in the event of a crash in an ambulance at up to 40 miles per hour.

UK Lebanon Tech Hub to fund research and development of non-invasive blood glucose-monitoring device

Fri, 26 May 2017 06:07:24 -0400

UK Lebanon Tech Hub announced today that it will fund the research and development of ediamond (Electromagnetic Diabetes Monitoring Device): a one of its kind non-invasive blood glucose-monitoring device, which is being developed by the Maroun Semaan faculty of Engineering and Architecture and the Faculty of Medicine at the American University of Beirut.

Attendance of UK MedTech companies highest recorded at CMEF

Fri, 26 May 2017 06:02:12 -0400

The largest delegation of UK healthcare companies took part in this year’s China Medical Equipment Fair (CMEF); waving the British flag for innovation in China.

Philips sponsors research to help COPD patients breathe easier

Fri, 26 May 2017 06:02:05 -0400

Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease (COPD) following a life-threatening respiratory event or exacerbation. The five-year, multi-center study resulted in prolonged median time to readmission or death by nearly three months, and improved patient health-related quality of life in the first six weeks.

Clinical study tests 100-year-old drug in children with autism spectrum disorder

Fri, 26 May 2017 05:55:45 -0400

In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.

Bouldering may be used to effectively treat symptoms of depression, study suggests

Fri, 26 May 2017 04:11:00 -0400

A growing body of research suggests that bouldering, a form of rock climbing, can help build muscle and endurance while reducing stress -- and a new study co-led by a University of Arizona doctoral student of psychology suggests that the activity also may be used to effectively treat symptoms of depression.

Gray matter density increases during transition from childhood to young adulthood, study reveals

Fri, 26 May 2017 03:44:00 -0400

For years, the common narrative in human developmental neuroimaging has been that gray matter in the brain - the tissue found in regions of the brain responsible for muscle control, sensory perception such as seeing and hearing, memory, emotions, speech, decision making, and self-control -- declines in adolescence, a finding derived mainly from studies of gray matter volume and cortical thickness (the thickness of the outer layers of brain that contain gray matter).

Health care providers should review Ebola response plans to avoid mistakes, say experts

Fri, 26 May 2017 03:14:39 -0400

With an Ebola outbreak underway in the Democratic Republic of Congo, experts say health care providers should review their Ebola response plans now to avoid repeating past mistakes.

Study reveals how enzyme allows brain tumors to grow despite harsh surroundings

Fri, 26 May 2017 02:53:48 -0400

All cancer tumors have one thing in common – they must feed themselves to grow and spread, a difficult feat since they are usually in a tumor microenvironment with limited nutrients and oxygen.